Amphastar Pharmaceuticals Inc
NASDAQ:AMPH
Amphastar Pharmaceuticals Inc
NASDAQ:AMPH
Price:
41.975 USD
-2.97%
Market Closed
Updated:
May 29, 2024
Amphastar Pharmaceuticals Inc
Total Current Liabilities
|
Amphastar Pharmaceuticals Inc
Total Current Liabilities Peer Comparison
Comparables:
JNJ
BMY
PFE
MRK
LLY
Competitive Total Current Liabilities Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Total Current Liabilities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Amphastar Pharmaceuticals Inc
NASDAQ:AMPH
|
Total Current Liabilities
$255.2m
|
CAGR 3-Years
26%
|
CAGR 5-Years
18%
|
CAGR 10-Years
13%
|
|
|
Johnson & Johnson
NYSE:JNJ
|
Total Current Liabilities
$48.7B
|
CAGR 3-Years
6%
|
CAGR 5-Years
11%
|
CAGR 10-Years
7%
|
|
|
Bristol-Myers Squibb Co
NYSE:BMY
|
Total Current Liabilities
$25.8B
|
CAGR 3-Years
14%
|
CAGR 5-Years
24%
|
CAGR 10-Years
13%
|
|
|
Pfizer Inc
NYSE:PFE
|
Total Current Liabilities
$40.5B
|
CAGR 3-Years
15%
|
CAGR 5-Years
7%
|
CAGR 10-Years
5%
|
|
|
Merck & Co Inc
NYSE:MRK
|
Total Current Liabilities
$25.1B
|
CAGR 3-Years
-2%
|
CAGR 5-Years
6%
|
CAGR 10-Years
1%
|
|
|
Eli Lilly and Co
NYSE:LLY
|
Total Current Liabilities
$18.6B
|
CAGR 3-Years
17%
|
CAGR 5-Years
11%
|
CAGR 10-Years
11%
|
See Also
What is Amphastar Pharmaceuticals Inc's Total Current Liabilities?
Total Current Liabilities
255.2m
USD
255.2m
USD
Based on the financial report for Mar 31, 2024, Amphastar Pharmaceuticals Inc's Total Current Liabilities amounts to 255.2m USD.
What is Amphastar Pharmaceuticals Inc's Total Current Liabilities growth rate?
Total Current Liabilities CAGR 10Y
13%
13%
Over the last year, the Total Current Liabilities growth was 142%. The average annual Total Current Liabilities growth rates for Amphastar Pharmaceuticals Inc have been 26% over the past three years , 18% over the past five years , and 13% over the past ten years .
You don't have any saved screeners yet
